Bart Dolmatch

Prostatic artery embolization (PAE) is a minimally invasive procedure for the management of benign prostatic hyperplasia (BPH), a common cause of lower urinary tract symptoms (LUTS) in older men.

Covered stents (also called stent grafts) have become one of the mainstays for treatment of hemodialysis access stenosis, with extensive data to support their use. Since the concept of a small-vessel covered stent was published 30 years ago,1 there have been many important covered-stent innovations that have improved outcomes for patients who rely upon hemodialysis for their survival.

The 2022 United States Renal Data System (USRDS) Annual Data Report tells us that in 2020 about 800,000 people in the United States had end-stage kidney disease/end-stage renal disease (ESKD/ESRD), of which nearly a half million were on hemodialysis and 65,000 adopted peritoneal dialysis.1 These numbers have grown dramatically over the past 2 decades, and despite a great deal of clinical investigation, we often lack “best-practice” approaches for the creation and maintenance of dialysis access.